InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| THP1-Dual™ KO-cGAS Cells | Immunotherapy With Engineered Bacteria by Targeting the STING Pathway for Ant... | 2020 | Nat Commun . | Leventhal D.S. et al. | DOI: 10.1038/s41467-020-16602-0. |
| 2'3'-c-di-AM(PS)2 (Rp,Rp) VacciGrade™ | Immunotherapy With Engineered Bacteria by Targeting the STING Pathway for Ant... | 2020 | Nat Commun . | Leventhal D.S. et al. | DOI: 10.1038/s41467-020-16602-0. |
| ADU-S100 | Immunotherapy With Engineered Bacteria by Targeting the STING Pathway for Ant... | 2020 | Nat Commun . | Leventhal D.S. et al. | DOI: 10.1038/s41467-020-16602-0. |
| QUANTI-Blue™ | Immunotherapy With Engineered Bacteria by Targeting the STING Pathway for Ant... | 2020 | Nat Commun . | Leventhal D.S. et al. | DOI: 10.1038/s41467-020-16602-0. |
| THP1-Dual™ KO-STING Cells | Immunotherapy With Engineered Bacteria by Targeting the STING Pathway for Ant... | 2020 | Nat Commun . | Leventhal D.S. et al. | DOI: 10.1038/s41467-020-16602-0. |
| QUANTI-Luc™: Luciferase Detection Reagent | Immunotherapy With Engineered Bacteria by Targeting the STING Pathway for Ant... | 2020 | Nat Commun . | Leventhal D.S. et al. | DOI: 10.1038/s41467-020-16602-0. |
| THP1-Dual™ Cells | Immunotherapy With Engineered Bacteria by Targeting the STING Pathway for Ant... | 2020 | Nat Commun . | Leventhal D.S. et al. | DOI: 10.1038/s41467-020-16602-0. |
| Anti-mouse Dectin-1 (CLEC7A) antibody | C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. | 2020 | Nature | Burberry A. et al. | 10.1038/s41586-020-2288-7 |
| LPS-EK (LPS from E. coli K12) | C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. | 2020 | Nature | Burberry A. et al. | 10.1038/s41586-020-2288-7 |
| R848 VacciGrade™ | C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. | 2020 | Nature | Burberry A. et al. | 10.1038/s41586-020-2288-7 |
| R848 (Resiquimod) | C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. | 2020 | Nature | Burberry A. et al. | 10.1038/s41586-020-2288-7 |
| Poly(I:C) HMW | C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. | 2020 | Nature | Burberry A. et al. | 10.1038/s41586-020-2288-7 |
| Pam3CSK4 | C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. | 2020 | Nature | Burberry A. et al. | 10.1038/s41586-020-2288-7 |
| PGN-BS peptidoglycan preparation | C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. | 2020 | Nature | Burberry A. et al. | 10.1038/s41586-020-2288-7 |
| Pam3CSK4 VacciGrade™ | C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. | 2020 | Nature | Burberry A. et al. | 10.1038/s41586-020-2288-7 |
| ODN 1826 - TLR9 ligand | C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. | 2020 | Nature | Burberry A. et al. | 10.1038/s41586-020-2288-7 |
| Zymosan | C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. | 2020 | Nature | Burberry A. et al. | 10.1038/s41586-020-2288-7 |
| Poly(I:C) (HMW) VacciGrade™ | C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. | 2020 | Nature | Burberry A. et al. | 10.1038/s41586-020-2288-7 |
| ODN 1826 VacciGrade™ | C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. | 2020 | Nature | Burberry A. et al. | 10.1038/s41586-020-2288-7 |
| ssRNA41/LyoVec™ | TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7–9 | 2020 | Nature | Heinz L.X. et al. | DOI: 10.1038/s41586-020-2282-0 |